We are live on ! Find out more
Vanguard Group

Vanguard Group Portfolio holdings

AUM $6.9T
1-Year Est. Return 27.45%
 

The Vanguard Group, founded in 1975 by John C. Bogle, is one of the world's largest investment management companies, headquartered in Malvern, Pennsylvania. As of recent years, it manages trillions in assets, offering a wide range of mutual funds, ETFs, and retirement products, catering to both individual and institutional investors. Its philosophy emphasizes low fees, diversification, and a buy-and-hold strategy, making it a dominant player in the passive investing revolution.

This Fund
S&P 500
This Quarter Est. Return
+9.42%
1 Year Est. Return
+27.45%
3 Year Est. Return
+121.04%
5 Year Est. Return
+156.26%
10 Year Est. Return
+538.59%
AUM
$2.93T
AUM Growth
+$236B
Cap. Flow
+$19B
Cap. Flow %
0.65%
Top 10 Hldgs %
16.4%
Holding
4,214
New
61
Increased
2,384
Reduced
1,277
Closed
87

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$3.46B
2
TFC icon
Truist Financial
TFC
+$2.5B
3
BABA icon
Alibaba
BABA
+$2.04B
4
UBER icon
Uber
UBER
+$1.04B
5
NOW icon
ServiceNow
NOW
+$937M

Sector Composition

Rank Sector Weight
1 Technology 18.84%
2 Financials 15%
3 Healthcare 13.05%
4 Consumer Discretionary 9.93%
5 Industrials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIEB icon
3301
Siebert Financial
SIEB
$68M
$3.31M ﹤0.01%
382,487
+804
+0.2% +$7.69K
BCLI
3302
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$3.3M ﹤0.01%
51,471
+346
+0.7% +$20.1K
FLL icon
3303
Full House Resorts
FLL
$79.4M
$3.3M ﹤0.01%
986,145
+14,000
+1% +$40.7K
VATE icon
3304
INNOVATE Corp
VATE
$101M
$3.3M ﹤0.01%
152,204
+4,902
+3% +$108K
MGI
3305
DELISTED
MoneyGram International, Inc. New
MGI
$3.3M ﹤0.01%
1,571,917
+294,174
+23% +$944K
LUMO
3306
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$3.3M ﹤0.01%
144,740
TRVN
3307
DELISTED
Trevena, Inc.
TRVN
$3.29M ﹤0.01%
6,265
WVE icon
3308
Wave Life Sciences
WVE
$1.19B
$3.29M ﹤0.01%
410,748
-666
-0.2% -$16.3K
GCAP
3309
DELISTED
Gain Capital Holdings, Inc.
GCAP
$3.27M ﹤0.01%
827,670
-2,447
-0.3% -$10.5K
ATLC icon
3310
Atlanticus Holdings
ATLC
$1.69B
$3.26M ﹤0.01%
361,612
+37,315
+12% +$295K
MBII
3311
DELISTED
Marrone Bio Innovations, Inc.
MBII
$3.23M ﹤0.01%
3,199,375
+508,459
+19% +$616K
AUBN icon
3312
Auburn National Bancorp
AUBN
$92.2M
$3.23M ﹤0.01%
60,942
+2,567
+4% +$114K
TRAK icon
3313
ReposiTrak
TRAK
$158M
$3.23M ﹤0.01%
638,093
HCM icon
3314
HUTCHMED
HCM
$2.06B
$3.21M ﹤0.01%
128,128
-15,298
-11% -$335K
EBMT icon
3315
Eagle Bancorp Montana
EBMT
$191M
$3.21M ﹤0.01%
149,921
+74,805
+100% +$1.48M
RNAC icon
3316
Cartesian Therapeutics
RNAC
$257M
$3.21M ﹤0.01%
44,896
-5,290
-11% -$255K
DHT icon
3317
DHT Holdings
DHT
$2.96B
$3.19M ﹤0.01%
385,000
+99,280
+35% +$736K
SYNC
3318
DELISTED
Synacor, Inc.
SYNC
$3.17M ﹤0.01%
2,083,944
+341
+0% +$533
HZN
3319
DELISTED
Horizon Global Corporation
HZN
$3.15M ﹤0.01%
903,380
+1,693
+0.2% +$6.27K
CRVS icon
3320
Corvus Pharmaceuticals
CRVS
$1.17B
$3.12M ﹤0.01%
574,227
+136
+0% +$476
AMPE
3321
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$3.12M ﹤0.01%
17,843
+4
+0% +$517
MRAM icon
3322
Everspin Technologies
MRAM
$367M
$3.11M ﹤0.01%
591,824
HWCC
3323
DELISTED
Houston Wire & Cable Company
HWCC
$3.11M ﹤0.01%
705,348
+47,000
+7% +$193K
LFT
3324
Lument Finance Trust
LFT
$35.5M
$3.1M ﹤0.01%
960,827
+237,077
+33% +$781K
GLOG
3325
DELISTED
GASLOG LTD
GLOG
$3.1M ﹤0.01%
316,342
+13,912
+5% +$158K

Similar funds

Vanguard Group's Q4 2019 Portfolio in Review

As of Q4 2019, Vanguard Group held 4,214 positions worth $2.93T, up 8.7% from $2.7T the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Trading was light in Q4 2019: portfolio turnover was 3.5%. Vanguard Group opened 61 new positions and exited 87, leaving the 4,214-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

  • Vanguard Group's largest Q4 2019 buy was Broadmark Realty Capital Inc. Common Stock: 8,851,056 shares worth $113M.
  • Vanguard Group added most to Bristol-Myers Squibb in Q4 2019, an estimated $3.46B increase.
  • Vanguard Group's biggest Q4 2019 reduction was Global Payments, cutting an estimated $641M.
  • Vanguard Group fully exited Celgene Corp in Q4 2019, selling an estimated $5.45B.
  • Vanguard Group's ten largest holdings make up 16% of its $2.93T portfolio in Q4 2019.
  • Vanguard Group opened 61 new positions and closed 87 in Q4 2019.
  • Vanguard Group's portfolio value rose 8.7% quarter-over-quarter to $2.93T.

Based on Vanguard Group's 13F filing for Q4 2019, filed 14 Feb 2020.